31st May 2018 14:35
VECTURA GROUP PLC (the "Company")
Chippenham, UK - 31 May 2018: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhaled product formulation, device design and development business, announces that Frank Condella, Non-Executive Director, joined the Board of Mayne Pharma Group Limited, an ASX-listed specialty pharmaceutical company with effect from 30 May 2018.
This information is disclosed to the London Stock Exchange in accordance with the requirements under paragraph 9.6.14R of the United Kingdom Listing Rules relating to the disclosure of changes to the roles, functions and responsibilities of directors.
- Ends -
Enquiries
Vectura Group plc | +44 (0)20 7881 0524 |
John Murphy Company Secretary | |
Consilium Strategic Communications | +44 (0)20 3709 5700 |
Mary-Jane Elliott / Susan Stuart/ Jessica Hodgson |
Related Shares:
VEC.L